Abstract
Calcium is a critically important mineral necessary for both intracellular and extracellular processes. Calcium circulates in the blood in an ionized state, bound to albumin and other serum proteins, and chelated to citrate, sulfate, and lactate. Only the free, ionized form of calcium is biologically active. Generally, total serum concentrations of calcium reflect the ionized calcium available to cells. However, there are two clinically important exceptions to this rule: 1) alkalosis will decrease ionized calcium concentration owing to an increase in the binding of calcium ions to albumin; and 2) in many chronic illnesses, substantial reductions in serum albumin concentrations occur, and this may lower total serum calcium concentrations while the ionized calcium concentration remains normal. The circulating level of ionized calcium is maintained in the physiologic range through the concerted actions of parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D, which mobilize calcium stores from bone and increase the efficiency of intestinal calcium absorption and renal calcium reabsorption. Hypocalcemia, in general, is an uncommon disorder. However, defects in the production or recognition of either PTH or 1,25-dihydroxyvitamin D, or a chronic deficiency of vitamin D, can precipitate hypocalcemia. Additionally, the removal of calcium from the circulation occasionally can exceed the capacity for correction by PTH and 1,25-dihydroxyvitamin D. In this section, the clinical presentations and appropriate therapeutic approaches for disorders associated with either deficient PTH or vitamin D action will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nusynowitz ML, Frame B, Kolb FO. The spectrum of hypoparathyroid states: A classification based on physiologic principles. Medicine 1976; 55: 105–119.
Winer KK, Yanovski JA, Cutler GB. Synthetic human parathyroid hormone 1–34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 1996; 276: 631–636.
Wozniewicz B, Migaj M, Giera B, Prokurat A, Tolloczko T, Sawicki A, et al. Cell culture preparation of human parathyroid cells for allotransplantation without immunosuppression. Trans Proc 1996; 28: 3542–3544.
Tolloczko T, Wozniewicz B, Sawicki A, Gorski A, Nawrot I, Zawitkowska T, Migaj M. Clinical results of human cultured parathyroid cell allotransplantation in the treatment of surgical hypoparathyroidism. Trans Proc 1996; 28: 3545, 3546.
Avioli LV. The therapeutic approach to hypoparathyroidism. Am J Med 1974; 57:34–42. 5a. Cardinale V (ed.). Drug Topics Red Book. Medical Economics, Montvale, NJ, 1997.
Okano K, Furukawa Y, Morii H, Fujita T. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism. J Clin Endocrinol Metab 1982; 55: 238–243.
Parfitt AM. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. J Clin Invest 1972; 51: 1879–1888.
Porter RH, Cox BG, Heaney D, Hostetter TH, Stinebaugh BJ, Suki WN. Treatment of hypoparathyroid patients with chlorthalidone. N Engl J Med 1978; 298: 577–581.
Drezner MK. Disorders of vitamin D metabolism: rickets and osteomalacia. In: Manolagos SC, Olefsky JM, eds. Metabolic Bone and Mineral Disorders, vol. 5. Churchill Livingstone, New York, 1988, pp 103–129.
Davies M, Adams PH. The continuing risk of vitamin D intoxication. Lancet 1978;i:621–623.
Holick MF. Vitamin D: Photobiology, metabolism, mechanism of action and clinical applications. In: Favus MJ, ed. Primer in the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Lippincott-Raven, Philadelphia, PA, 1996, pp. 74–81.
McKenna MJ, Frame B. Privational vitamin D deficiency. Comprehen Ther 1987; 13: 54–61.
Reber PM, Heath H III. Hypocalcemia emergencies. Med Clin N Am 1995; 79: 93–107.
Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985; 313: 70–73.
Dawson-Hughes B, Dallai GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Int Med 1991; 115: 505–512.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Klein, R.F., Bliziotes, M., Orwoll, E.S. (1999). Parathyroid Hormone and Vitamin D Replacement Therapy. In: Meikle, A.W. (eds) Hormone Replacement Therapy. Contemporary Endocrinology, vol 13. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-700-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-59259-700-0_5
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-092-2
Online ISBN: 978-1-59259-700-0
eBook Packages: Springer Book Archive